REGN : REGENERON PHARMACEUTICALS stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-03-21 |
|---|---|---|---|---|
| 2023 | $891.21 | $797.42 | $961.39 | 17.3% |
| 2024 | $1012.4 | $889.85 | $1165.08 | 33.25% |
| 2025 | $948.17 | $725.49 | $1130.64 | 24.8% |
| 2026 | $629.32 | $571.1 | $685.93 | -17.17% |
| 2027 | $459.04 | $386.12 | $544.89 | -39.58% |
| 2028 | $271.99 | $200.61 | $367.89 | -64.2% |
| 2029 | $227.22 | $179.15 | $342.06 | -70.09% |
| 2030 | $512.8 | $368.47 | $637.98 | -32.51% |
| 2031 | $691.76 | $648.31 | $837.86 | -8.95% |
| 2032 | $1029.03 | $890.82 | $1134.68 | 35.44% |
| 2033 | $1175.76 | $1154.68 | $1197.23 | 54.75% |
The 27 Wall Street analysts offering REGENERON PHARMACEUTICALS stock forecast in the last 6 months have average price target of
$843.85 with a high forecast of $1025.0 and a low forecast of $750.0.
The average REGENERON PHARMACEUTICALS stock forecast represents a 11.07%
increase from the last price of $759.760009765625.
From AI system, total return is 2366.52% from 4098 forecasts.
For REGENERON PHARMACEUTICALS stock forecast for 2023, 9 predictions are offered for each month of 2023 with average REGENERON PHARMACEUTICALS stock
forecast of $891.21, a high forecast of $961.39, and a low forecast of $797.42.
The average REGENERON PHARMACEUTICALS stock forecast 2023 represents a 17.3%
increase from the last price of $759.760009765625.
For REGENERON PHARMACEUTICALS stock forecast for 2024, 12 predictions are offered for each month of 2024 with average REGENERON PHARMACEUTICALS stock
forecast of $1012.4, a high forecast of $1165.08, and a low forecast of $889.85.
The average REGENERON PHARMACEUTICALS stock forecast 2024 represents a 33.25%
increase from the last price of $759.760009765625.
For REGENERON PHARMACEUTICALS stock forecast for 2026, 12 predictions are offered for each month of 2026 with average REGENERON PHARMACEUTICALS stock
forecast of $629.32, a high forecast of $685.93, and a low forecast of $571.1.
The average REGENERON PHARMACEUTICALS stock forecast 2026 represents a -17.17%
decrease from the last price of $759.760009765625.
For REGENERON PHARMACEUTICALS stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average REGENERON PHARMACEUTICALS stock
forecast of $271.99, a high forecast of $367.89, and a low forecast of $200.61.
The average REGENERON PHARMACEUTICALS stock forecast 2028 represents a -64.2%
decrease from the last price of $759.760009765625.
For REGENERON PHARMACEUTICALS stock forecast for 2031, 12 predictions are offered for each month of 2031 with average REGENERON PHARMACEUTICALS stock
forecast of $691.76, a high forecast of $837.86, and a low forecast of $648.31.
The average REGENERON PHARMACEUTICALS stock forecast 2031 represents a -8.95%
decrease from the last price of $759.760009765625.
For REGENERON PHARMACEUTICALS stock forecast for 2033 (10 year), 3 predictions are offered for each month of 2033 with average REGENERON PHARMACEUTICALS stock
forecast of $1175.76, a high forecast of $1197.23, and a low forecast of $1154.68.
The average REGENERON PHARMACEUTICALS stock forecast 2033 represents a 54.75%
increase from the last price of $759.760009765625.
Please, see more forecasts below.
REGN : REGENERON PHARMACEUTICALS stock forecast by Wall Street Analysts
The average REGENERON PHARMACEUTICALS stock forecast from last 6 month is $843.85, and this show a 4.22% increase in average from the prior price target of the each prediction. Also, this average forecast of $843.85 represents a 20.47% increase from the past average forecast of $700.45, 6 months ago from 22 wall street analysts.
REGENERON PHARMACEUTICALS stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-03-23 | $771.75 | 1.58% |
| 2023-03-24 | $795.03 | 3.02% |
| 2023-03-27 | $761.63 | -4.20% |
| 2023-03-28 | $778.17 | 2.17% |
| 2023-03-29 | $767.19 | -1.41% |
REGN : Long term REGENERON PHARMACEUTICALS stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Apr. is $797.42 , for 2024 Mar. is $904.73 , for 2027 Mar. is $504.32 , for 2028 Mar. is $322.49 , for 2032 Mar. is $968.82 , and for 2033 Mar. is $1197.23.
REGN : REGENERON PHARMACEUTICALS stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Apr. | $797.42 | 4.96% |
| 2023 May. | $829.75 | 4.05% |
| 2023 Jun. | $852.23 | 2.71% |
| 2023 Jul. | $876.11 | 2.80% |
| 2023 Aug. | $915.00 | 4.44% |
| 2023 Sep. | $961.39 | 5.07% |
| 2023 Oct. | $941.21 | -2.10% |
| 2023 Nov. | $924.92 | -1.73% |
| 2023 Dec. | $922.88 | -0.22% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $904.05 | -2.04% |
| 2024 Feb. | $889.85 | -1.57% |
| 2024 Mar. | $904.73 | 1.67% |
| 2024 Apr. | $900.02 | -0.52% |
| 2024 May. | $921.69 | 2.41% |
| 2024 Jun. | $962.85 | 4.47% |
| 2024 Jul. | $1010.69 | 4.97% |
| 2024 Aug. | $1067.23 | 5.59% |
| 2024 Sep. | $1116.89 | 4.65% |
| 2024 Oct. | $1152.97 | 3.23% |
| 2024 Nov. | $1165.08 | 1.05% |
| 2024 Dec. | $1152.77 | -1.06% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $1130.64 | -1.92% |
| 2025 Feb. | $1099.22 | -2.78% |
| 2025 Mar. | $1061.91 | -3.39% |
| 2025 Apr. | $1022.53 | -3.71% |
| 2025 May. | $985.06 | -3.66% |
| 2025 Jun. | $958.32 | -2.71% |
| 2025 Jul. | $949.66 | -0.90% |
| 2025 Aug. | $929.71 | -2.10% |
| 2025 Sep. | $893.94 | -3.85% |
| 2025 Oct. | $843.81 | -5.61% |
| 2025 Nov. | $777.78 | -7.83% |
| 2025 Dec. | $725.49 | -6.72% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $685.93 | -5.45% |
| 2026 Feb. | $659.91 | -3.79% |
| 2026 Mar. | $643.18 | -2.53% |
| 2026 Apr. | $632.80 | -1.61% |
| 2026 May. | $626.36 | -1.02% |
| 2026 Jun. | $625.25 | -0.18% |
| 2026 Jul. | $632.04 | 1.09% |
| 2026 Aug. | $633.93 | 0.30% |
| 2026 Sep. | $633.04 | -0.14% |
| 2026 Oct. | $614.65 | -2.90% |
| 2026 Nov. | $593.71 | -3.41% |
| 2026 Dec. | $571.10 | -3.81% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $544.89 | -4.59% |
| 2027 Feb. | $522.56 | -4.10% |
| 2027 Mar. | $504.32 | -3.49% |
| 2027 Apr. | $487.51 | -3.33% |
| 2027 May. | $471.73 | -3.24% |
| 2027 Jun. | $457.52 | -3.01% |
| 2027 Jul. | $445.24 | -2.68% |
| 2027 Aug. | $436.38 | -1.99% |
| 2027 Sep. | $430.56 | -1.33% |
| 2027 Oct. | $419.02 | -2.68% |
| 2027 Nov. | $402.60 | -3.92% |
| 2027 Dec. | $386.12 | -4.09% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $367.89 | -4.72% |
| 2028 Feb. | $345.83 | -6.00% |
| 2028 Mar. | $322.49 | -6.75% |
| 2028 Apr. | $301.95 | -6.37% |
| 2028 May. | $285.36 | -5.50% |
| 2028 Jun. | $271.63 | -4.81% |
| 2028 Jul. | $258.96 | -4.66% |
| 2028 Aug. | $246.00 | -5.01% |
| 2028 Sep. | $232.87 | -5.34% |
| 2028 Oct. | $220.57 | -5.28% |
| 2028 Nov. | $209.75 | -4.90% |
| 2028 Dec. | $200.61 | -4.36% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $193.04 | -3.77% |
| 2029 Feb. | $186.96 | -3.15% |
| 2029 Mar. | $182.35 | -2.47% |
| 2029 Apr. | $179.44 | -1.59% |
| 2029 May. | $179.15 | -0.16% |
| 2029 Jun. | $184.37 | 2.91% |
| 2029 Jul. | $198.61 | 7.73% |
| 2029 Aug. | $223.51 | 12.53% |
| 2029 Sep. | $254.96 | 14.07% |
| 2029 Oct. | $286.66 | 12.43% |
| 2029 Nov. | $315.48 | 10.05% |
| 2029 Dec. | $342.06 | 8.43% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $368.47 | 7.72% |
| 2030 Feb. | $394.82 | 7.15% |
| 2030 Mar. | $421.22 | 6.69% |
| 2030 Apr. | $447.71 | 6.29% |
| 2030 May. | $474.81 | 6.05% |
| 2030 Jun. | $502.79 | 5.89% |
| 2030 Jul. | $531.25 | 5.66% |
| 2030 Aug. | $559.14 | 5.25% |
| 2030 Sep. | $584.73 | 4.58% |
| 2030 Oct. | $606.51 | 3.72% |
| 2030 Nov. | $624.13 | 2.90% |
| 2030 Dec. | $637.98 | 2.22% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $648.31 | 1.62% |
| 2031 Feb. | $654.82 | 1.00% |
| 2031 Mar. | $657.89 | 0.47% |
| 2031 Apr. | $659.21 | 0.20% |
| 2031 May. | $659.41 | 0.03% |
| 2031 Jun. | $660.09 | 0.10% |
| 2031 Jul. | $662.84 | 0.42% |
| 2031 Aug. | $670.46 | 1.15% |
| 2031 Sep. | $688.25 | 2.65% |
| 2031 Oct. | $723.80 | 5.17% |
| 2031 Nov. | $778.23 | 7.52% |
| 2031 Dec. | $837.86 | 7.66% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $890.82 | 6.32% |
| 2032 Feb. | $934.92 | 4.95% |
| 2032 Mar. | $968.82 | 3.63% |
| 2032 Apr. | $993.03 | 2.50% |
| 2032 May. | $1010.85 | 1.79% |
| 2032 Jun. | $1026.58 | 1.56% |
| 2032 Jul. | $1042.23 | 1.52% |
| 2032 Aug. | $1059.12 | 1.62% |
| 2032 Sep. | $1077.00 | 1.69% |
| 2032 Oct. | $1095.53 | 1.72% |
| 2032 Nov. | $1114.82 | 1.76% |
| 2032 Dec. | $1134.68 | 1.78% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $1154.68 | 1.76% |
| 2033 Feb. | $1175.37 | 1.79% |
| 2033 Mar. | $1197.23 | 1.86% |
Frequently Asked Questions about REGENERON PHARMACEUTICALS stock forecast
Is REGENERON PHARMACEUTICALS a good long term stock?
From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2023 Apr. is $797.416936377575 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2024 Mar. is $904.733618217336 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2027 Mar. is $504.319161950527 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2028 Mar. is $322.494192795246 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2032 Mar. is $968.824931009132 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2033 Mar. is $1197.22931063063
Is REGENERON PHARMACEUTICALS stock overvalued?
REGENERON PHARMACEUTICALS (REGN) stock is expected to go UP . Therefore, Tudal would say that REGENERON PHARMACEUTICALS (REGN) stock is NOT overvalued.
Will REGENERON PHARMACEUTICALS stock price go up?
Yes. The REGENERON PHARMACEUTICALS stock price forecast for 2024 Mar. is $904.733618217336
Is REGENERON PHARMACEUTICALS stock a good buy now?
Since closing price on 2023-03-21 is $759.760009765625 and forecast for 2024 Mar. is $904.73, REGENERON PHARMACEUTICALS stock is a good 1 year investment.